Skip to main content

World Law Alliance

UNBOUNDED™  ·  Barcelona · 14–15 August 2026 · Hyatt Regency Barcelona Tower  ·  Registration Open — 45 spots remaining REGISTER NOW
Sign In
WLA CO-PRACTICE CORRIDOR · IN DEVELOPMENT · positions open

India → Latin America
South-South. Pharmaceutical. Technology. Emerging corridor.

India–Latin America is a fast-emerging south-south corridor — driven by Indian pharmaceutical companies supplying Latin American healthcare markets, Indian IT services expanding into Brazilian and Colombian tech, and growing Indian PE and corporate investment into Latin American middle market companies.

+19%
Deal activity growth
$20bn+
India-LatAm total trade
Both Ways
Pharma · IT · fintech
2026
All founding positions open
IN DEVELOPMENT · 2026
BOTH SIDES OPEN · FOUNDING POSITIONS AVAILABLE NOW
This corridor is under active development. All founding positions are open. 2026 founding status is permanent and cannot be acquired retroactively.
APPLY NOW →
HOW CO-PRACTICE WORKS ON THIS CORRIDOR

BOTH SIDES OPEN.
FOUNDING POSITIONS
AVAILABLE NOW.

This corridor is under active development. Founding Corridor Leader positions on both sides are open to qualifying WLA partner firms — 2026 founding status is permanent and cannot be acquired retroactively.

INDIA LEGAL SIDE
Indian M&A law — Companies Act 2013, FEMA Overseas Investment Rules 2022 for India outbound investment into Latin America
Indian pharmaceutical regulatory — DCGI and CDSCO compliance for Indian pharma companies exporting to LatAm markets
Indian tax — Income Tax Code 2025, India-Brazil DTAA, India-Mexico DTAA planning for India-LatAm investment structures
Indian IT services — Indian software export framework and SEZ compliance for IT services delivered into Latin American markets
FEMA OI Rules • RBI — Indian outbound investment into Latin American subsidiaries and JVs under OI Rules 2022
CGPDTM — Indian IP strategy co-ordinated with INPI Brazil, IMPI Mexico, and Latin American IP offices simultaneously
CORRIDOR LEADER · INDIA · FOUNDING POSITION OPEN
THIS POSITION
IS OPEN.
IS THAT YOUR FIRM?

The INDIA Corridor Leader position on the India → Latin America corridor is open for a founding WLA partner firm. Permanent 2026 founding status. Named on every WLA brief, every Intelligence publication, and UNBOUNDED™ in perpetuity.

Named India → Latin America INDIA Corridor Leader — published permanently across all WLA platforms
All corridor mandates on this side route through your firm as the designated co-practice lead
Corridor intelligence co-produced under your firm's name — quarterly, published globally
Named at UNBOUNDED™ Barcelona 2026 and all future editions in perpetuity
2026 Founding status is permanent and non-retroactive — cannot be purchased after 2026
USD 2,995 per year · Non-binding EOI · Response within 2 to 3 working days
APPLY FOR THIS POSITION →
LATIN AMERICA LEGAL SIDE
Brazil — Lei das S.A., CADE merger control, BACEN capital registration, ANVISA pharmaceutical regulatory approval
Mexico — COFECE merger control, Ley General de Salud (COFEPRIS) pharmaceutical licensing, Investment Law
Colombia — SIC merger control, INVIMA pharmaceutical registration, Investment Statute for Indian-origin capital
Chile — FNE merger control, ISP pharmaceutical registration, Foreign Investment Law
Argentina — ANMAT pharmaceutical regulatory, BCRA foreign exchange, Antitrust Law
Peru — INDECOPI, DIGEMID pharmaceutical registration, Foreign Investment Law for Indian pharmaceutical investment
CORRIDOR LEADER · LATIN · FOUNDING POSITION OPEN
THIS POSITION
IS OPEN.
IS THAT YOUR FIRM?

The LATIN Corridor Leader position on the India → Latin America corridor is open for a founding WLA partner firm. Permanent 2026 founding status. Named on every WLA brief, every Intelligence publication, and UNBOUNDED™ in perpetuity.

Named India → Latin America LATIN Corridor Leader — published permanently across all WLA platforms
All corridor mandates on this side route through your firm as the designated co-practice lead
Corridor intelligence co-produced under your firm's name — quarterly, published globally
Named at UNBOUNDED™ Barcelona 2026 and all future editions in perpetuity
2026 Founding status is permanent and non-retroactive — cannot be purchased after 2026
USD 2,995 per year · Non-binding EOI · Response within 2 to 3 working days
APPLY FOR THIS POSITION →
ACTIVE SECTORS

WHERE THE DEAL
FLOW IS MOVING
ON THIS CORRIDOR.

WLA holds specialists in All nine WLA core practices across both sides of this corridor simultaneously.

💊
Pharmaceuticals

Indian generic pharmaceutical companies supplying 30%+ of Latin American medicine needs. Indian pharma establishing LatAm manufacturing.

↑ Very High
💻
IT Services & Technology

Indian IT services companies with Brazil and Mexico delivery operations. Indian tech companies expanding into LatAm digital market.

↑ High
💰
Private Equity & Investment

Indian PE houses looking at Latin American middle market. Indian conglomerates acquiring LatAm companies.

↑ High
🌿
Agriculture & Agri-Tech

India-Brazil agricultural technology exchange. Indian precision agriculture technology into LatAm farming markets.

↑ Moderate
🏦
Financial Services

Indian fintech companies entering Brazilian and Mexican digital financial services markets. India-Brazil payment infrastructure.

↑ Moderate
✦ WLA EXCLUSIVE PRACTICE PARTNERS · INDIA → LATIN AMERICA

SPECIALISTS ON
BOTH SIDES.
DIRECT ACCESS.

Each firm holds one exclusive practice on this corridor. Reachable directly — no desk required.

No firms designated yet for this corridor.

Exclusive practice positions are open for firms interested in holding a designation on this corridor.

Apply for a designation →
CORRIDOR INTELLIGENCE · LIVE

REGULATORY SIGNALS
ACROSS BOTH SIDES
OF THIS CORRIDOR.

WLA tracks regulatory changes and deal climate signals on this corridor in real time.

SIGNAL
DETAIL
STATUS
DCGI ANVISA
PHARMA REGULATORY
Indian Pharma — DCGI-ANVISA Brazil and COFEPRIS Mexico Dual Regulatory Compliance
Indian pharmaceutical companies must navigate country-by-country regulatory frameworks across Latin America. ANVISA Brazil and COFEPRIS Mexico are the primary regulatory bodies. WLA co-practices Indian DCGI with LatAm pharma regulatory compliance.
ACTIVE
FEMA OI RULES
INDIA OUTBOUND
FEMA OI Rules 2022 — Indian Outbound Investment into LatAm Under New Framework
FEMA Overseas Investment Rules 2022 significantly changed Indian outbound investment. Indian companies investing in Latin American subsidiaries must comply. WLA monitors compliance requirements for all corridor participants.
ACTIVE
INDIA BRAZIL DTAA
TAX
India-Brazil DTAA — Withholding Tax and Transfer Pricing Planning
India-Brazil double taxation avoidance agreement planning critical for Indian companies with Brazilian operations. Royalties, services fees, and dividends withholding tax co-ordination required.
HIGH
BRAZIL TRANSFER PRICING
OECD
Brazil OECD Transfer Pricing — Material Impact on Indian Groups with Brazilian Operations
OECD-aligned transfer pricing rules in Brazil now affect Indian IT and pharma groups with Brazilian operations and intra-group transactions. WLA co-practices Indian and Brazilian transfer pricing simultaneously.
HIGH
INDIA LATAM
TRADE FRAMEWORK
India-Mercosur Preferential Trade Agreement — Expansion Discussions Active
India-Mercosur PTA expansion discussions ongoing. India-Mexico FTA negotiations at early stage. WLA monitors India-LatAm trade framework development for corridor participants.
WATCH
WHAT WLA CO-PRACTICES

SIX PRACTICES.
BOTH SIDES.
SIMULTANEOUSLY.

WLA holds all six core practice areas on both sides of this corridor.

01

INDIAN PHARMA INTO LATIN AMERICA

Indian generic pharmaceutical companies manufacturing and distributing across Latin American markets — WLA co-practices Indian DCGI export compliance with ANVISA Brazil, COFEPRIS Mexico, INVIMA Colombia, and DIGEMID Peru regulatory authorisation simultaneously.

02

INDIAN IT SERVICES → BRAZIL AND MEXICO

Indian IT services companies with Brazilian and Mexican delivery operations — WLA co-practices Indian corporate and FEMA outbound law with Brazilian and Mexican corporate, employment, and data protection law.

03

INDIAN PE → LATIN AMERICAN MIDDLE MARKET

Indian PE and corporate investment into Brazilian, Colombian, and Chilean businesses — CADE/SIC/FNE merger control, BACEN registration, country-specific compliance — co-practiced with Indian FEMA OI Rules simultaneously.

04

INDIA-BRAZIL DTAA AND TRANSFER PRICING

India-Brazil DTAA planning and OECD-aligned Brazilian transfer pricing compliance for Indian groups with Brazilian operations — WLA co-practices Indian and Brazilian tax simultaneously as one integrated cross-border tax programme.

05

INTELLECTUAL PROPERTY — CGPDTM + INPI BRAZIL + IMPI MEXICO

Indian IP portfolio management co-ordinated with INPI Brazil, IMPI Mexico, and other Latin American IP offices simultaneously — one integrated programme with enforcement strategy across all corridor jurisdictions.

06

DISPUTE RESOLUTION — CAM-CCBC + ICC + INDIAN ARBITRATION

India-Latin America commercial dispute resolution — CAM-CCBC Brazil, ICC, and Singapore SIAC for international disputes. WLA holds both corridor sides from pre-dispute strategy through award enforcement.

FOUNDING POSITIONS · 2026 · BOTH SIDES OPEN

FOUNDING STATUS
ON THIS CORRIDOR.
PERMANENT. 2026.

Both INDIA side and LATIN side Corridor Leader positions are open. 2026 founding status is permanent and non-retroactive — it cannot be acquired after 2026.

Corridor Leader — USD 2,995 per corridor per year · Founding status permanent
Exclusive Practice Partner — USD 995 per practice per year · One firm per jurisdiction
Non-binding EOI · Response within 2 to 3 working days · Confidential
APPLY FOR A POSITION ON THIS CORRIDOR

Non-binding · Confidential · Response within 2 to 3 working days

BRIEF WLA ON
THIS CORRIDOR.
within 48 HOURS.